Investments abroad · Private equity · Netherlands
Forbion Capital Partners' investments in the United States
Forbion Capital Partners, based in the Netherlands, has backed 25 startups in the United States in rounds we track, $4.6B between them, grouped by their main sector.
Forbion Capital Partners's whole portfolioForbion Capital Partners's profile
Biotech
17
Funding by segment
- Biotech$3.1B17
- Pharma$1.3B6
- Healthtech$209M2
Where they are based
- United States25$4.6B
United StatesFounded
7 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M0
- $50M to $250M22
- $250M to $1B3
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 25 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States25
Startups by country, 1 country in all.
Segment by segment
Biotech
17 startups · $3.1B raised
Dyne TherapeuticsDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.United States$828M
Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
Beacon TherapeuticsBeacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States$247M
Marea TherapeuticsMarea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.United States$190M
Braveheart BioBraveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.United States$185M
Crescent BiopharmaCrescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.United States$185M- CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
Mariana OncologyMariana Oncology is a biotechnology research industry.United States$175M
Pharma
6 startups · $1.3B raised
MapLight TherapeuticsMapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.United States$523M- ABAiolos BioAiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.United States$245M
Solstice OncologySolstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.United States$225M
Protego BiopharmaProtego Biopharma is a California-based biotechnology company that researches and develops small-molecule therapeutics for the treUnited States$130M
Sling TherapeuticsSling Therapeutics is a private biopharmaceutical company based in Ann Arbor, Michigan.United States$123M
Rampart BioscienceRampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically drUnited States$85M
Healthtech
2 startups · $209M raised
Engrail TherapeuticsEngrail Therapeutics is a clinical-stage pharmaceutical company based in San Diego, California, founded in 2019.United States$157M- PMPathway Medical TechnologiesPathway Medical Technologies develops, manufactures and markets medical devices for the treatment of arterial disease.United States$52M
How this map is made. Every startup here has raised money in a round we track that names Forbion Capital Partners as an investor and is based in United States. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Forbion Capital Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.